B6.129P2-B2mtm1Unc/Orl
Status | Available to order |
EMMA ID | EM:00029 |
International strain name | B6.129P2-B2mtm1Unc/Orl |
Alternative name | beta2m° |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | B2mtm1Unc |
Gene/Transgene symbol | B2m |
Information from provider
Provider | Beverly H. Koller |
Provider affiliation | c/o CDTA-Orleans |
Phenotypic information | The B2M protein is linked to MHC class I molecules. The mutant mice carry a null mutation in the beta-2 microglobulin (B2m) gene. Obtained by mutation of the B2m gene by homologous recombination (insertion of neomycin-resistance gene). Class I molecules are lacking or unstable on the cell surface, leading to a nearly elimination of the T CD8+ compartment. Cytotoxic immune responses are much altered. |
Breeding history | 129P2/OlaHsd ES cells; 9 generations of backcross to C57BL/6, then intercross. |
References |
|
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Immunodeficiency by defective expression of MHC class I / Orphanet_34592
- Variant ABeta2M amyloidosis / Orphanet_314652
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- decreased level of surface class I molecules / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- decreased IgG level / MGI
- abnormal pancreas morphology / MGI
- decreased susceptibility to bacterial infection / MGI
- increased IgM level / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- decreased circulating serum albumin level / MGI
- increased T-helper 1 cell number / MGI
- abnormal interleukin level / MGI
- abnormal tumor necrosis factor level / MGI
- increased susceptibility to infection induced morbidity/mortality / MGI
- absent CD8-positive, alpha-beta T cells / MGI
- abnormal pancreatic beta cell morphology / MGI
- abnormal T cell number / MGI
- insulitis / MGI
MGI phenotypes (gene matching)
- absent CD8-positive, alpha-beta T cells / MGI
- decreased IgG level / MGI
- decreased level of surface class I molecules / MGI
- abnormal pancreas morphology / MGI
- decreased susceptibility to bacterial infection / MGI
- abnormal CD8-positive, alpha-beta cytotoxic T cell morphology / MGI
- increased IgM level / MGI
- insulitis / MGI
- abnormal lateral geniculate nucleus morphology / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- decreased susceptibility to parasitic infection / MGI
- abnormal cytotoxic T cell physiology / MGI
- abnormal pancreatic beta cell morphology / MGI
- decreased circulating serum albumin level / MGI
- hemochromatosis / MGI
- abnormal T cell number / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- increased T-helper 1 cell number / MGI
- increased gamma-delta T cell number / MGI
- increased gamma-delta intraepithelial T cell number / MGI
- increased tumor necrosis factor secretion / MGI
- increased interleukin-3 secretion / MGI
- decreased interleukin-4 secretion / MGI
- abnormal interleukin level / MGI
- abnormal tumor necrosis factor level / MGI
- increased susceptibility to infection induced morbidity/mortality / MGI
Literature references
- Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.;Koller B H, Marrack P, Kappler J W, Smithies O, ;1990;Science (New York, N.Y.);248;1227-30; 2112266
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).